FDA issues recall notice for Philips after another respiratory device fails
The FDA has issued the notice for the company’s Trilogy EVO Continuous Ventilators, warning that they are liable to be ‘battery depleted’ despite being connected to power and halting therapy.
Profound wins FDA clearance for AI support to Tulsa system
FDA warns users not to use Cue Health’s at-home Covid-19 tests
Skin in the game: the latest issue of Medical Technology is out now
Rakovina expands collaborations to leverage AI platform